Quale sarebbe il prezzo per Vaxil Bio Ltd. (VXL)

Il prezzo per Vaxil Bio Ltd. (VXL) è $0.1174299

Qual è la capitalizzazione di mercato per Vaxil Bio Ltd. (VXL)

La capitalizzazione di mercato per Vaxil Bio Ltd. (VXL) è $467.84K

Vaxil Bio Ltd. (VXL) Rendimento del Dividendo

Vaxil Bio Ltd. is a biotechnology firm dedicated to discovering and developing innovative therapeutic agents. Its foundation lies in a unique signal peptide-based platform, which it leverages to address critical health challenges, specifically infectious diseases and various cancers. The company's primary therapeutic candidate, ImMucin, has successfully advanced through Phase I/II clinical trials as a potential treatment for multiple myeloma. Beyond ImMucin, Vaxil Bio is actively developing a vaccine/treatment for tuberculosis, as well as a vaccine targeting coronavirus (COVID-19). Strategic alliances bolster its research efforts; Vaxil Bio collaborates with The Tel Aviv Sourasky Medical Center on a research initiative to create a peptide-based COVID-19 vaccine. Furthermore, it holds a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Infectious Diseases to assess CorVax's efficacy in preventing COVID-19 in murine models. Established in 2006, the company's operations are based in Toronto, Canada.

Anno	Rendimento da dividendi	Cambia
Non abbastanza dati per le date fornite.

Anno

Rendimento da dividendi

Cambia

Non abbastanza dati per le date fornite.

Azienda	Rendimento da dividendi	Il paese
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Lonza Group AG LONN.SW	0.00%	CH
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	KR
UCB S.A. UCB.BR	0.65%	BE

Azienda

Rendimento da dividendi

Il paese